Matches in Nanopublications for { ?s ?p "[MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP235359.RAYpFd5iE-NO7_j156X6W00IJPu-CibI6W4rti9wIfwdk130_assertion description "[MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235359.RAYpFd5iE-NO7_j156X6W00IJPu-CibI6W4rti9wIfwdk130_provenance.
- NP952475.RA1IgsBD5O98PlHM6F3W8W5WDxpqiNIHVz4Ftkq4FNzIg130_assertion description "[MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952475.RA1IgsBD5O98PlHM6F3W8W5WDxpqiNIHVz4Ftkq4FNzIg130_provenance.
- NP578919.RAPagtCKxZAN1TJaggvUiQjY2kvME2TiXcZPWYRRKfbho130_assertion description "[MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578919.RAPagtCKxZAN1TJaggvUiQjY2kvME2TiXcZPWYRRKfbho130_provenance.
- NP952480.RAlZ3jc0PKNsJCi00PZZuXeIDC7uz6O33hBNZbGeyCGb4130_assertion description "[MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952480.RAlZ3jc0PKNsJCi00PZZuXeIDC7uz6O33hBNZbGeyCGb4130_provenance.